Q3 PERSPECTIVE: Some of the most consequential decisions affecting a company's future are made outside its own boardroom. For the dietary supplement industry, legislative and regulatory decisions can shape everything from operating costs and market access to innovation and growth.
- Q3 demonstrated what's at stake. In California, CRN's advocacy helped prevent costly labeling changes, while new age restrictions created additional business challenges. In Washington, a longstanding CRN priority advanced into legislation that could provide greater certainty for ingredient innovation.
- The opportunity to influence these decisions comes before they're final. Early engagement gives companies a voice in shaping policy, rather than simply absorbing the consequences.
For executives, the strategic question is whether their companies are helping shape change, not just ready to respond to it.
Learn how your company can benefit from being part of the CRN member community.
Questions? Please contact CRN Senior Director of Membership Ed Wyszumiala (ewyszumiala@crnusa.org / 989-598-5275).

